All In Biotech

Drug Trial Radar · NCT05990192

SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy

SOPRANO: Stereotactic Radiotherapy Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARP Inhibitor Therapy

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

42

Planned (sponsor's estimate)

Start

Jun 20, 2024

Primary completion

Dec 31, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
Institute of Cancer Research, United KingdomAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Royal Marsden NHS Foundation Trust
First posted
Aug 14, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

SOPRANO is a multi-centre phase II trial designed to assess the impact of SBRT with or without continuing treatment with a PARP inhibitor (PARPi) for patients with oligometastatic or oligoprogressive ovarian, fallopian tube and primary peritoneal carcinoma. SOPRANO will also establish the feasibility and acceptability of delivering SBRT in this setting.

Conditions

  • Ovarian Cancer Recurrent

Interventions

  • Niraparib oral capsuleDrug

    Niraparib used following SBRT treatment until disease progression

  • SBRTRadiation

    SBRT may be delivered using a specialist SBRT platform, such as CyberKnife or with a linear accelerator with SBRT capabilities.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression free survivalTime frame: The primary timepoint of most interest for PFS is at six months after trial entry

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • The Royal Marsden NHS Foundation Trust

    London, United Kingdom · Recruiting

  • Southampton General Hospital

    Southampton, United Kingdom · Recruiting

  • St James's University Hospital

    Leeds, Leeds, United Kingdom · Recruiting

  • Leicester Royal Infirmary

    Leicester, Leicester, United Kingdom · Recruiting

  • The Christie NHS Foundation Trust

    Manchester, Manchester, United Kingdom · Recruiting

  • Western General Hospital

    Edinburgh, Scotland, United Kingdom · Recruiting

  • The Royal Marsden NHS Foundation Trust

    Sutton, Surrey, United Kingdom · Recruiting

  • University College London Hospitals

    London, UK, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.